Diabetes
-
Tandem recalls Mobi insulin pump, reports 230 adverse events
A problem with a false occlusion alarm could interrupt insulin delivery for users, according to an entry in the FDA’s recall database.
By Elise Reuter • Nov. 11, 2026 -
Tandem Diabetes Care names next CEO
Jeannette Bankes will take over the role from John Sheridan, who will retire at the end of the year after leading the company since 2019.
By Elise Reuter • Nov. 6, 2026 -
Explore the Trendline➔
Courtesy of Johnson & Johnson
TrendlineNew medical devices are reshaping the medtech industry
From pulsed field ablation devices to glucose sensors and surgical robotics, new medical technologies are transforming patient care and how people manage their health.
By MedTech Dive staff -
MiniMed names David Segal chief medical officer
Segal is succeeding Robert Vigersky, who is transitioning to a chief medical officer emeritus role ahead of his planned retirement at the end of next year.
By Nick Paul Taylor • Nov. 5, 2026 -
Abbott, Dexcom grapple with diabetes coverage ahead of planned Medicare expansion
Abbott said it is facing pricing pressure and slower growth ahead of a planned coverage expansion for people with Type 2 diabetes. Competitor Dexcom, however, did not experience the same slowdown.
By Elise Reuter • Nov. 2, 2026 -
FDA clears Sequel’s insulin delivery system in Type 2 diabetes
With Twiist already available in Type 1 diabetes, Sequel has made the automated insulin delivery system available for the Type 2 population.
By Nick Paul Taylor • Oct. 19, 2026 -
MiniMed completes separation from Medtronic
Medtronic exchanged all of its remaining shares of the diabetes technology spinoff.
By Elise Reuter • Oct. 16, 2026 -
NEJM study supports CGM use for people with diabetes who don’t take insulin
The results come as Dexcom is awaiting a decision from the Centers for Medicare and Medicaid Services to expand Medicare coverage of the devices for people with Type 2 diabetes.
By Elise Reuter • Oct. 15, 2026 -
Ascensia leads $36M funding round for glucose sensor startup
Ascensia also struck an exclusive sales agreement with Sava, which is making a wearable to continuously monitor glucose and other biomarkers.
By Elise Reuter • Oct. 12, 2026 -
Dexcom gives CFO Jereme Sylvain expanded role
Sylvain will work as chief operating officer of the diabetes technology company while continuing as its CFO.
By Nick Paul Taylor • Sept. 16, 2026 -
Beta Bionics’ insulin patch pump gets FDA nod
By bringing its first patch pump to market, Beta Bionics will be able to compete with industry leader Insulet.
By Elise Reuter • Sept. 14, 2026 -
Medtronic begins final steps to separate MiniMed
The separation will allow Medtronic to focus on its cardiovascular, neuroscience and surgical portfolios, CEO Geoff Martha said.
By Elise Reuter • Sept. 14, 2026 -
MiniMed submits new patch pump for FDA clearance
The diabetes tech firm is preparing for the launch of new devices, including a tubeless insulin pump and a fully closed loop automated insulin delivery system.
By Elise Reuter • Sept. 1, 2026 -
Dexcom, Abbott await Medicare coverage expansion for CGMs
Dexcom CEO Jake Leach said he is watching for a decision by the federal health insurance program before the end of the year.
By Elise Reuter • Aug. 27, 2026 -
Abbott receives FDA nod for dual-analyte sensor
Abbott plans to roll out the device, called Libre Duo 10 Day, later this year. The sensor can measure both glucose and ketones.
By Elise Reuter • Aug. 25, 2026 -
MiniMed starts shipping new insulin pump with Abbott-made sensor
The company has begun a major marketing campaign to support the launch of its MiniMed Flex insulin pump.
By Nick Paul Taylor • Aug. 24, 2026 -
Deep Dive
5 questions on Abbott’s glucose-ketone sensors
As Abbott prepares to launch its first dual-analyte sensor, endocrinologists talked to MedTech Dive about considerations for continuous ketone monitoring.
By Elise Reuter • Aug. 19, 2026 -
Q&A
Inside Senseonics’ commercial overhaul and what’s next
The diabetes tech firm recently brought its sales and marketing teams in-house after taking over commercialization of its device from Ascensia Diabetes Care.
By Elise Reuter • Aug. 13, 2026 -
Abbott, Google to combine glucose data with AI coaching
The multiyear partnership will connect Abbott’s over-the-counter Lingo sensor and the Google Health app.
By Elise Reuter • Aug. 12, 2026 -
FDA names Dexcom as first participant in digital health pilot
Selected devices will be exempt from certain premarket requirements while manufacturers collect real-world data through Medicare.
By Elise Reuter • July 23, 2026 -
Insulet launches Omnipod 5 in Spain
A high rate of continuous glucose monitor adoption and low level of automated insulin delivery system penetration make Spain an attractive market for Insulet.
By Nick Paul Taylor • July 7, 2026 -
MiniMed launches Abbott-made Instinct glucose sensor in Europe
Overseas markets are central to MiniMed’s business, accounting for 70% of reported net sales in the company’s 2026 financial year.
By Nick Paul Taylor • June 24, 2026 -
Insulet hires first chief R&D officer amid growing competition
Divakar Ramakrishnan brings experience from Convatec and Eli Lilly. Insulet said the new hire was an important step in strengthening the company’s innovation capabilities.
By Elise Reuter • June 23, 2026 -
4 diabetes tech execs on the future of multi-analyte glucose sensors
Executives with Abbott, PercuSense and Biolinq spoke with MedTech Dive about what’s next with multi-analyte sensor technology.
By Elise Reuter • June 22, 2026 -
In a first, Dexcom’s OTC glucose sensor is cleared for kids
The Stelo over-the-counter glucose monitor can now be used by children as young as two years.
By Elise Reuter • June 15, 2026 -
Top medtech stories from ADA’s Scientific Sessions
Dexcom, Abbott, MiniMed and Insulet featured upcoming technologies at the American Diabetes Association’s annual event. Catch up on news coming out of the conference.
By Elise Reuter • June 12, 2026